Reporting of clinical trial results

LEO Pharma considers it an ethical and scientific responsibility to report the results of our clinical trials.

LEO Pharma considers it an ethical and scientific responsibility to report the results of our clinical trials. By ensuring that all our clinical trial results are accessible, we minimise the risk for biased and selective reporting.

A key part of our efforts to increase clinical trial transparency is the guarantee that people taking part in our trials can access the trial results. The people taking part in our trials are informed about when and where the trial results will become available, and they receive a thank-you note for their valuable contribution.

Public data registries

LEO Pharma's clinical trial results are reported according to applicable laws and regulations and international recommendations on:

• www.clinicaltrials.gov

• www.clinicaltrialsregister.eu

• various national registries.

Results are reported after a clinical trial has been completed or stopped, regardless of the outcome, according to set timelines by the governing authority. 

Starting September 2019*, we publish the results of all trials with products that are approved anywhere in the world on the global public registry clinicaltrials.gov.

*Refers to the year of the clinical trial protocol.